Alzheimer’s disease drug firm Alzamend Neuro stock pops 571% (NYSE:DPW)

Alzheimer’s disease drug developer Alzamend Neuro (Nasdaq:ALZN) soared nearly 600% within minutes of opening Tuesday following an IPO, prompting multiple trading halts.
Read More